Showing 31,841 - 31,860 results of 103,867 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 1.54s Refine Results
  1. 31841
  2. 31842
  3. 31843
  4. 31844
  5. 31845
  6. 31846

    Fabrication of Recyclable Polyisoprene Elastomers with Tuneable Mechanical Properties by Incorporating Dynamic Bonds and Separated Polystyrene Phase by Meijuan Xie (8427819)

    Published 2024
    “…The experimental results show that the flow of PS phases above <i>T</i><sub>g,PS</sub> effectively accelerates the rearrangement of dynamic covalent networks, so that the exchange activation energy (<i>E</i><sub>a</sub>) and topological freezing transition temperature (<i>T</i><sub>v</sub>) of the samples decrease with the increase of the PS phase content, giving the samples superior recyclability and self-healing ability. …”
  7. 31847

    DataSheet1_Integrated Proteomics and Metabolomics Link Acne to the Action Mechanisms of Cryptotanshinone Intervention.ZIP by Zhaoming Zhu (8136090)

    Published 2021
    “…These results propose action mechanisms for the use of CPT in acne, as a safe and potential new drug.</p>…”
  8. 31848
  9. 31849
  10. 31850
  11. 31851

    Table_1_Causal relationship between dietary intake and IgA nephropathy: a Mendelian randomization study.xls by Yaping Li (399717)

    Published 2024
    “…</p>Conclusion<p>Our study provided genetic evidence that alcohol intake frequency was associated with an increased risk of IgAN, while cheese, cereal, and sushi intake were associated with a decreased risk of IgAN. Further investigation is required to confirm these results.…”
  12. 31852
  13. 31853
  14. 31854
  15. 31855

    <i>chb-3</i> encodes a novel protein with a zf-MYND motif. by Manabi Fujiwara (236721)

    Published 2010
    “…Y50C1, Y2F4 (<i>C. elegans</i> genomic YAC clone), and a Y48G1A.3 PCR fragment (6.5 kb) which contained the Y48G1A.3 predicted gene and 1 kb of upstream sequence, rescued the Daf-c phenotype of <i>chb-3(eg52)</i>. …”
  16. 31856

    Image_3_A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis.pdf by Federica Ciregia (450383)

    Published 2021
    “…Five A-SAA variants (SAA1α, SAA1β, SAA1γ, SAA2α, and SAA2β) but also S100A8 and S100A9 proteins were simultaneously quantified in plasma applying a method based on single targeted bottom-up proteomics LC-MS/MS. …”
  17. 31857

    Image_1_A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis.pdf by Federica Ciregia (450383)

    Published 2021
    “…Five A-SAA variants (SAA1α, SAA1β, SAA1γ, SAA2α, and SAA2β) but also S100A8 and S100A9 proteins were simultaneously quantified in plasma applying a method based on single targeted bottom-up proteomics LC-MS/MS. …”
  18. 31858

    Image_4_A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis.pdf by Federica Ciregia (450383)

    Published 2021
    “…Five A-SAA variants (SAA1α, SAA1β, SAA1γ, SAA2α, and SAA2β) but also S100A8 and S100A9 proteins were simultaneously quantified in plasma applying a method based on single targeted bottom-up proteomics LC-MS/MS. …”
  19. 31859

    DataSheet_1_A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis.pdf by Federica Ciregia (450383)

    Published 2021
    “…Five A-SAA variants (SAA1α, SAA1β, SAA1γ, SAA2α, and SAA2β) but also S100A8 and S100A9 proteins were simultaneously quantified in plasma applying a method based on single targeted bottom-up proteomics LC-MS/MS. …”
  20. 31860

    Image_2_A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis.pdf by Federica Ciregia (450383)

    Published 2021
    “…Five A-SAA variants (SAA1α, SAA1β, SAA1γ, SAA2α, and SAA2β) but also S100A8 and S100A9 proteins were simultaneously quantified in plasma applying a method based on single targeted bottom-up proteomics LC-MS/MS. …”